Potential diagnosis of COVID-19 from chest X-ray and CT findings using semi-supervised learning

A review of deep learning-based reconstruction methods for accelerated MRI using spatiotemporal and multi-contrast redundancies

Accelerated magnetic resonance imaging (MRI) has played an essential role in reducing data acquisition time for MRI. Acceleration can be achieved by acquiring fewer data points in k-space, which results in various artifacts in the image domain. Conventional reconstruction methods have resolved the artifacts by utilizing multi-coil information, but with limited robustness. Recently, numerous deep learning-based reconstruction methods have been developed, enabling outstanding reconstruction performances with higher acceleration. Advances in hardware and developments of specialized network architectures have produced such achievements. Besides, MRI signals contain various redundant information including multi-coil redundancy, multi-contrast redundancy, and spatiotemporal redundancy. Utilization of the redundant information combined with deep learning approaches allow not only higher acceleration, but also well-preserved details in the reconstructed images. Consequently, this review paper introduces the basic concepts of deep learning and conventional accelerated MRI reconstruction methods, followed by review of recent deep learning-based reconstruction methods that exploit various redundancies. Lastly, the paper concludes by discussing the challenges, limitations, and potential directions of future developments.

A Systematic Review on Deep Structured Learning for COVID-19 Screening Using Chest CT from 2020 to 2022

The emergence of the COVID-19 pandemic in Wuhan in 2019 led to the discovery of a novel coronavirus. The World Health Organization (WHO) designated it as a global pandemic on 11 March 2020 due to its rapid and widespread transmission. Its impact has had profound implications, particularly in the realm of public health. Extensive scientific endeavors have been directed towards devising effective treatment strategies and vaccines. Within the healthcare and medical imaging domain, the application of artificial intelligence (AI) has brought significant advantages. This study delves into peer-reviewed research articles spanning the years 2020 to 2022, focusing on AI-driven methodologies for the analysis and screening of COVID-19 through chest CT scan data. We assess the efficacy of deep learning algorithms in facilitating decision making processes. Our exploration encompasses various facets, including data collection, systematic contributions, emerging techniques, and encountered challenges. However, the comparison of outcomes between 2020 and 2022 proves intricate due to shifts in dataset magnitudes over time. The initiatives aimed at developing AI-powered tools for the detection, localization, and segmentation of COVID-19 cases are primarily centered on educational and training contexts. We deliberate on their merits and constraints, particularly in the context of necessitating cross-population train/test models. Our analysis encompassed a review of 231 research publications, bolstered by a meta-analysis employing search keywords (COVID-19 OR Coronavirus) AND chest CT AND (deep learning OR artificial intelligence OR medical imaging) on both the PubMed Central Repository and Web of Science platforms.

Detection of stage of lung changes in COVID-19 disease based on CT images: a radiomics approach

The aim of this study is to classify patients suspected from COVID-19 to five stages as normal, early, progressive, peak, and absorption stages using radiomics approach based on lung computed tomography images. Lung CT scans of 683 people were evaluated. A set of statistical texture features was extracted from each CT image. The people were classified using the random forest algorithm as an ensemble method based on the decision trees outputs to five stages of COVID-19 disease. Proposed method attains the highest result with an accuracy of 93.55% (96.25% in normal, 74.39% in early, 100% in progressive, 82.19% in peak, and 96% in absorption stage) compared to the other three common classifiers. Radiomics method can be used for the classification of the stage of COVID-19 disease with good accuracy to help decide the length of time required to hospitalize patients, determine the type of treatment process required for patients in each category, and reduce the cost of care and treatment for hospitalized individuals.